Local News

• Johnson & Johnson extends tender offer for Mentor Corporation  Johnson & Johnson announced it has extended its previously announced cash tender offer, through its wholly owned subsidiary, Maple Merger Sub, for all outstanding shares of common stock of Mentor Corporation until 5:00 p.m. (Eastern time), on January 16, 2009, unless further extended.
  Johnson & Johnson January 06, 2009  
• Monsanto announces yield gains with Deltapine Class Of 09  Monsanto Company announced its D&PL business will market five new varieties as the Deltapine Class of 09 for the coming production season. These varieties were introduced during the 2009 Beltwide Cotton Conferences that have brought the cotton industry together in San Antonio.
  Monsanto Company January 06, 2009  
• Abbott completes acquisition of Ibis Biosciences, a subsidiary of Isis  Isis Pharmaceuticals and Abbott announced that Abbott has completed its purchase of Ibis Biosciences, an Isis subsidiary, for a closing purchase price of $175 million.
  Isis Pharmaceuticals, Inc. January 06, 2009  
• MedImmune submits Marketing Authorisation Application in EU for intranasal flu vaccine  MedImmune, the global biologics unit of AstraZeneca, announced that it has submitted a Marketing Authorisation Application (MAA) for its nasal spray live attenuated influenza vaccine (LAIV), which is now being reviewed by the European Medicines Agency (EMEA).
  AstraZeneca January 06, 2009  
• PNNL proteomics scientist named rising young star  Wei-Jun Qian, a scientist at Pacific Northwest National Laboratory, is one of 30 "rising young stars" named by Genome Technology magazine. Qian is an expert in proteomics — the study of proteins. His work is giving a better understanding of cell signaling and protein biomarkers for human diseases.
  Pacific Northwest National Laboratory January 06, 2009  
• Forbes Medi-Tech receives extension to compliance deadline  Forbes Medi-Tech announced that the Company received a letter from The Nasdaq Stock Market stating that NASDAQ has decided to extend its suspension of the bid price and market value of publicly held shares requirements.
  Forbes Medi-Tech Inc. January 05, 2009  
• Dick Bond leaving Tyson Foods  Dick Bond, president and chief executive officer of Tyson Foods, announced he is leaving the company, effective immediately. Leland Tollett, former chairman and CEO of the company, has agreed to return to the company as President and CEO on an interim basis.
  Tyson Foods, Inc. January 05, 2009  
• PPD enters into strategic collaboration with Merck  PPD announced it has entered into a strategic collaboration with Merck & Co. involving vaccine testing and assay development. Under the agreements, PPD purchased Merck's 130,000 square-foot vaccine testing laboratory and related equipment in Wayne, Penn.
  PPD, Inc. January 05, 2009  
• FDA Cardio Renal Advisory Committee to review Daiichi Sankyo, Lilly drug prasugrel  Daiichi Sankyo Company and Eli Lilly and Company confirmed that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) will review prasugrel during an advisory committee hearing on February 3, 2009.
  Eli Lilly and Company December 31, 2008  
• CV Technologies announces management cease trade order  CV Technologies announces that a management cease trade order has been issued by the Alberta Securities Commission.
  CV Technologies Inc. December 31, 2008  

   (next 10 articles)